Marcela Haro, PhD, earned her doctoral degree from Wake Forest University. As a graduate student, she trained with Karen Haas, PhD, where her research focused on the mechanisms regulating B cell responses to tumor associated carbohydrate antigens. She is interested in the roles of B cells in ovarian cancer progression and the influence of cancer associated fibroblasts in the anti-tumor B cell response.
Ye Hu, MD, PhD, earned her doctoral and medical degrees from Shanghai Jiao Tong University School of Medicine, China. As a graduate student, she trained with Jingyuan Fang, MD, PhD, where her research focused on the development and progression of gastrointestinal tumors. After finishing her residency, Hu joined the Orsulic Laboratory. She is interested in the role of cancer-associated fibroblasts in shaping the immune composition of tumors and their potential as a therapeutic target.
Yael Raz Yana, MD, PhD obtained her medical degree in 2007 from the Hebrew University Hadassah Medicine School in Jerusalem, Israel. In 2017, she completed her OB-GYN residency at Lis Maternity & Women's Hospital—Tel Aviv Sourasky Medical Center, focusing on gynecologic oncology. During her residency she also completed her doctorate thesis project "Characterizing the Role of Cancer-Associated Fibroblasts in Breast Cancer and Lung Metastasis" in the lab of Neta Erez, PhD, at the Sackler Faculty of Medicine at Tel Aviv University. Raz Yana is interested in fibroblasts and immune cell recruitment in cancer and the co-evolution of the metastatic stroma during cancer progression.
Barbie Taylor-Harding, PhD, earned her doctoral degree in molecular biology from the University of London, UK. She trained with Nicholas Dyson, PhD, at Massachusetts General Hospital Cancer Center and Harvard Medical School, where her research focused on the molecular mechanisms underlying cancer development. She currently performs managerial duties within the Women’s Cancer Program and works in the Orsulic Laboratory, where her research interests focus on improving therapeutic efficacy and identifying predictive markers of clinical outcomes in ovarian cancer.
Maria Recouvreux, PhD, earned her doctorate at the Faculty of Exact and Natural Sciences at the University of Buenos Aires in Argentina. Her doctoral research focused on the role of progesterone receptor isoforms in the regulation of normal and cancer stem cells in the mammary gland. Recouvreux's current research focuses on precancerous lesions in the fallopian tube and factors that contribute to malignant changes in the fallopian tube epithelial cells.
Enes Taylan, MD, earned his medical degree at the Ankara University Medical School in Turkey. He completed his residency in obstetrics and gynecology at the Ege University School of Medicine in Izmir, Turkey, where he subsequently served as an attending physician. Prior to joining the Orsulic laboratory, Taylan conducted research with Kutluk Oktay, MD, PhD, at Yale School of Medicine in New Haven, Connecticut. His research focused on ovarian aging and oncofertility with the goal of developing new treatment options to preserve fertility in women undergoing chemotherapy due to cancer.
Jingni Wu, MD, earned her medical degree from Xiangya Medical College of Central South University (CSU) in China. She completed her residency in obstetrics and gynecology at the Second Xiangya Hospital of CSU. Her research with Xiaoling Fang, MD, PhD, focused on the role of autophagy in endometriosis. In the Orsulic Laboratory, Wu’s research focuses on the roles of fallopian tube secretory and ciliated cells in the formation of the precancer niche.